3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-1H-indole, 95.0%, 500mg

5-Hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid, 95.0%, 100mg

TERT-BUTYL 4-HYDROXY-3-METHYL-4-(TRIFLUOROMETHYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 2g

5-(Tetrahydro-2H-pyran-4-yl)-1H-pyrazol-3-amine, 95.0%, 1g

(1,2,3,4-Tetrahydronaphthalen-1-yl)methanol, 95%, 250mg

(S)-2,2'-Dimethyl-1,1'-binaphthyl>98.0%(HPLC)5g

Quinoline-4,7-diol, 95.0%, 1g

MITOXANTRONE, 95%, 25mg

(2S)-2-amino-6-[(carboxymethyl)amino]hexanoic acid, 98.0%, 5mg

1-(Benzyloxy)-2,3-difluoro-4-nitrobenzene, 97%, 1g

(R)-1-Boc-3-Benzylpiperazine, 95.0%, 5g

GC capillary column ROTI®Cap-5 MS, 25 m, 0.32 mm, 1.00 µm, 1 Piece(s)

METHYL 4-FLUORO-1H-INDAZOLE-6-CARBOXYLATE, 95%, 10g